semaglutide and mood changes A new era of weight loss: Mental health effects of GLP-1 drugs Clinic Pack:Pouch Semaglutide Weight Loss Injections

semaglutide and mood changes A new era of weight loss: Mental health effects of GLP-1 drugs Clinic Pack:Pouch Semaglutide Weight Loss Injections

Semaglutide Weight Loss Injections & Clinics Near You | Flagstaff, AZ

Phase 2 trial data (published in New England Journal of Medicine, 2023 ): 24.2% average weight loss at 48 weeks with 12 mg dose 22.8% with 8 mg dose Placebo group lost 2.1% Most recent Phase 3 trial data (TRIUMPH-4, December 2025): 28.7% average weight loss at 68 weeks with 12 mg dose 26.4% with 9 mg dose 58.6% of participants on 12 mg achieved at least 25% weight loss 39.4% achieved at least 30% weight loss For context: These are the highest weight loss numbers reported in any clinical trial for a pharmacological obesity treatment

Clinic

Pack:Pouch

Retatrutide is an investigational injectable medicine currently under clinical development for the treatment of obesity and type 2 diabetes